3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
44
Lymphoma, Mantle-Cell
22
Lymphoma, Non-Hodgkin
15
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma, Follicular
10
Waldenstrom Macroglobulinemia
9
Lymphoma
9
Lymphoma, B-Cell, Marginal Zone
7
Leukemia
7
Recurrence
6
Neoplasms
6
Lymphoma, B-Cell
5
Leukemia, B-Cell
5
Bronchiolitis Obliterans Syndrome
5
Multiple Myeloma
3
Leukemia, Lymphoid
3
Hematologic Diseases
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Melanoma
2
Leukemia, Prolymphocytic
2
Leukemia, Hairy Cell
2
Hematologic Neoplasms
2
Glioblastoma
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neurologic Manifestations
1
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
ibrutinib
×
1 year
×
Clear all
No trials found.